RT Journal Article
SR Electronic
T1 Post COVID-19 sequelae: A prospective observational study from Northern India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.28.21259658
DO 10.1101/2021.06.28.21259658
A1 Naik, Shivdas
A1 Soneja, Manish
A1 Haldar, Soumendra
A1 Mundadan, Netto George
A1 Garg, Prerna
A1 Mittal, Ankit
A1 Desai, Devashish
A1 Trilangi, Praveen Kumar
A1 Chakraborty, Sayan
A1 Begam, Nazneen Nahar
A1 Bhattacharya, Bisakh
A1 Maher, Ganesh
A1 Kumar, Swathi S
A1 Kirthana, J
A1 Arunan, Bharathi
A1 Gupta, Ankesh
A1 Mahishi, Niranjan
A1 Rajanna, Chaitra
A1 Parsoon, Prateek
A1 Kumar, Nikhil A
A1 Maharatna, Sayan
A1 Bhattacharya, Akashneel
A1 Keri, Vishakh C
A1 Samed, Sameer A
A1 Adarsh, AK
A1 Shareef, Imtiyaz
A1 Ravela, Neeren
A1 Swain, Satish
A1 Sarda, Radhika
A1 Kadnur, Harshith B
A1 Dudhwal, Ashok
A1 Agarwal, Ayush
A1 Vedula, Kartik
A1 Gupta, Ashish
A1 Agarwal, Shubham
A1 Anand, R
A1 Lalikar, Pratima
A1 Jagtap, Pallavi
A1 Premjeet, B
A1 Kodan, Parul
A1 Sethi, Prayas
A1 Ray, Animesh
A1 Jorwal, Pankaj
A1 Kumar, Arvind
A1 Nischal, Neeraj
A1 Sinha, Sanjeev
A1 Biswas, Ashutosh
A1 Wig, Naveet
YR 2021
UL http://medrxiv.org/content/early/2021/07/01/2021.06.28.21259658.abstract
AB Background Long COVID, or post-COVID-19 sequelae, is being seen in a growing number of patients reporting a constellation of symptoms, both pulmonary and extrapulmonary. Studies on COVID-19 recovered patients are scarce. Thus, there is a need to add granularity to our existing knowledge about the course and long-term effects of the infection.Aim To describe the clinical details and risk factors of post-COVID sequelae in the North Indian population.Method This prospective observational study was conducted at a tertiary healthcare centre in Northern India between October 2020 to February 2021. Patients aged >18 years with a confirmed COVID-19 disease were recruited after at least two weeks of diagnosis and interviewed for any post-COVID-19 symptoms.Results Of 1234 patients recruited, who were followed up for a median duration of 91 days (IQR: 45-181 days), 495 (40.11%) patients had symptoms. In 223 (18.1%) patients, the symptoms resolved within four weeks, 150 (12.1%) patients had symptoms till twelve weeks, and 122 (9.9%) patients had symptoms beyond twelve weeks of diagnosis of COVID-19. Most common long COVID-19 symptoms included myalgia (10.9%), fatigue (5.5%), shortness of breath (6.1%), cough (2.1%), disturbed sleep (1.4%), mood disturbances (0.48%) and anxiety (0.6%). The major determinants of developing post-COVID-19 symptoms in the patients were hypothyroidism and the severity of the disease.Conclusion Most often, patients complain of myalgias, fatigue, dyspnoea, cough and disturbed sleep. Patients who are hypothyroid or have recovered from moderate to severe COVID-19 are at higher risk of developing post-COVID sequelae. Therefore, a multidisciplinary approach is required to diagnose and manage COVID-19 recovered patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was cleared by the institutional ethics committee of AIIMS, New Delhi (IECPG/162/4/2020)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe data is available with the first author and can be produced on a reasonable request